A combination therapy of gemcitabine, capecitabine and bevacizumab improves outcomes in patients with advanced pancreatic cancer, according to a multi-center study led by researchers at Roswell Park Cancer Institute in Buffalo, N.Y. Read the rest of this entry »
Jun
4
3-Drug Combo Improves Advanced Pancreatic Cancer Outcomes
genetic | 
Articles, Cancer, Clinical Trials, Drug Trials, News, Oncology | 
06 4th, 2008| 
No Comments »
genetic | Articles, Cancer, Clinical Trials, Drug Trials, News, Oncology | 06 4th, 2008| No Comments »
Jun
4
Avastin Added to Chemo Helps Women With Advanced Cancer
genetic | Articles, Biochemistry, Cancer, Clinical Research, Clinical Trials, Drug Discovery, Drug Trials, News, Oncology | 06 4th, 2008| No Comments »
genetic | Articles, Biochemistry, Cancer, Clinical Research, Clinical Trials, Drug Discovery, Drug Trials, News, Oncology | 06 4th, 2008| No Comments »Adding the drug Avastin to chemotherapy lengthened progression-free survival in women with advanced breast cancer, new research shows. Read the rest of this entry »